Drugs / Regulator T Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06411184 | Jun 2024 → Dec 2025 overdue | graft versus host disease | Xuzhou Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Regulator T Cells | “Drug: Regulator T Cells” NCT06411184 ↗ |
| Modality | Cell therapy | “Autologous Regulatory T-Lymphocytes” NCT06411184 ↗ |